SecBot SecBot
PRESS-RELEASE ·Filed May 11, 2026

STE

STERIS plc
MIXED
Impact 6/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

The EPS miss vs consensus is modest but may weigh on the stock near-term. However, FY27 guidance of 9-11% EPS growth and 6-7% organic revenue growth, plus the $1B buyback, provide a supportive floor. Watch the earnings call for commentary on tariff impacts and Healthcare segment margin trajectory.

DirectionMixed
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

STERIS reported fiscal Q4 2026 adjusted EPS of $2.83, slightly above the $2.74 prior year but below the $2.85 consensus estimate. Revenue grew 7% to $1.6B, in line with the $1.6B consensus. The company guided fiscal 2027 adjusted EPS of $11.10-$11.30 (9-11% growth) and constant currency organic revenue growth of 6-7%, while announcing a new $1B share buyback program. The EPS miss relative to consensus and tariff/inflation headwinds are offset by solid revenue growth and positive guidance.

Key Financial Metrics

EPS
$2.83
est $2.85 · -0.7%
Revenue
$1.6B
est $1.6B · 0.0% · +7.0% YoY
Rating
in line
Guidance
~$6.3B (implied by 7-8% growth on $5.9B base)
raised
Free Cash Flow
$982.9M

Key Facts

  • Fiscal Q4 2026 adjusted EPS $2.83 vs consensus $2.85 (miss) and prior year $2.74
  • Fiscal Q4 2026 revenue $1.6B, +7% YoY, in line with consensus
  • Full year fiscal 2026 adjusted EPS $10.17, +10.3% YoY
  • Full year fiscal 2026 revenue $5.9B, +9% YoY; constant currency organic growth 7%
  • Fiscal 2027 guidance: adjusted EPS $11.10-$11.30 (9-11% growth), constant currency organic revenue growth 6-7%
  • New $1B share repurchase program authorized
  • Free cash flow fiscal 2026 $982.9M, up from $787.2M prior year
  • Tariffs and inflation partially offset volume/price gains in Healthcare segment

Financial Impact

Q4 adjusted EPS $2.83 vs $2.85 consensus (-0.7% miss); revenue $1.6B in line; FY27 guidance implies ~$6.3B revenue and ~$11.20 EPS midpoint

revenueepsfree cash flowshare buyback

Risk Factors

  • Tariffs and inflation continue to pressure Healthcare segment margins
  • Constant currency organic growth of 6-7% in FY27 is below FY26's 7%, potential deceleration
  • Capital equipment revenue in AST declined 62% YoY in Q4, signaling lumpy demand
  • Effective tax rate assumption of ~25% for FY27 could be a headwind if actual rate is higher

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3292377

Track record

21 reports on STE

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +17.96% at T+20 after the Oct 13, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $264.32 Now $261.91 −0.91% settles Nov 23
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
  3. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $253.44 Now $261.91 +3.34% settles Nov 19
  5. Nov 10, 20266d ago 144 Neutral 2/10 Entry $256.27 Now $261.91 +2.20% settles Nov 18
  6. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
  9. Oct 28, 202619d ago Press Release Neutral 2/10 Entry $232.14 to $254.12 Now $261.91 +12.82% ▲ +9.47% +14.19% vs SPY
  10. Oct 20, 202627d ago Press Release Neutral 1/10 Entry $221.48 to $228.49 Now $261.91 +18.25% ▲ +3.17% +3.61% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (14h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026